ASH News Daily 2015 - Day 3 - (Page B-1)

ASH NEWS DAILY ® 57th Annual Meeting of the American Society of Hematology Issue 3, Section B Monday, December 7, 2015 Orlando, FL Read this issue online at www.hematology.org/ashnewsdaily2015_monday Follow us on Twitter using #ASH15 SCHEDULE 7:00 a.m. - 5:00 p.m. Registration Orange County Convention Center West Building, Level 1 Concourse 7:00 - 8:30 a.m. Education Program 7:00 - 8:30 a.m. Simultaneous Oral Sessions 10:00 a.m. - 2:00 p.m. Exhibits Open 10:00 a.m. - 8:00 p.m. Poster Session III - Viewing Orange County Convention Center (Hall A2 - A3) 10:30 a.m. - 12:00 noon Simultaneous Oral Sessions 10:30 a.m. - 12:00 noon Education Program 12:15 - 1:15 p.m. Product Theaters in Exhibit Hall Orange County Convention Center (Exhibit Hall A4 - B4) 12:15 - 1:15 p.m. Trainee Simultaneous Didactic Sessions Open only to trainees wearing a blue badge 2:45 - 4:15 p.m. Simultaneous Oral Sessions 2:45 - 4:15 p.m. Education Program 4:30 - 6:00 p.m. Simultaneous Oral Sessions 6:00 - 8:00 p.m. Poster Session III - Presentations Orange County Convention Center (Hall A2 - A3) 6:00 - 8:00 p.m. Poster Hall Reception 6:15 - 7:45 p.m. Simultaneous Oral Sessions IN THIS SECTION LATP Award B-4 Visitor Training Program B-5 CRTI-LA B-6 Trainee Sessions & Services B-8 Dr. John C. Byrd, from Humble Beginnings to a Thriving Career in Hematology J ohn C. Byrd, MD, will be pre- of Arkansas, Dr. Byrd learned a lessented with the 2015 William son early on, which he would conDameshek Prize, named after tinue to apply throughout his career William Dameshek, MD, past and that would help him in the longrun. "Coming from a ASH president and blue collar family and original editor of Blood. having worked as a laDr. Byrd will be acceptborer, waiter, food haning the award at 9:30 dler, cook, and factory a.m. tomorrow during worker taught me the the Announcement of importance of humility Awards (Hall D, Orand respect for all inange County Convendividuals in whatever tion Center). He is the they do." And despite D. Warren Brown Chair his professional accomof Leukemia Research plishments, Dr. Byrd is at The Ohio State Uniquick to point out that versity College of Medhis contributions are icine. He is also the Dijust one piece of a much rector of the Division of John C. Byrd, MD larger mosaic. When Hematology and Proasked about receiving gram Co-Leader of the Leukemia Research Program in The the Dameshek award, he stressed Ohio State University Comprehen- that he is part of a collective of scientists working together to find new sive Cancer Center. Growing up in the poorest county and important drugs to treat patients with chronic lymphocytic leukemia (CLL). "It is incredibly humbling to be individually identified for being worthy of the Dameshek award," he states. "This validates externally the work our team has directed toward developing new treatment approaches for patients with CLL and other hematologic malignancies. I feel truly blessed to be part of this team and grateful to all those who have worked together with me in this mission." Throughout his more than 20-year career, Dr. Byrd has revolutionized the way CLL is viewed and treated, developing and defining the mechanism of action of the anti-CD20 antibody rituximab, which was the first therapy to prolong survival in CLL. He also led the pre-clinical and clinical development of the targeted therapy ibrutinib. He acknowledges »» DAMESHEK PRIZE Page B-26 Dr. Karl Welte and Dr. Nancy A. Speck: Drawn to Science from the Very Beginning K 9:30 a.m. during the Anarl Welte, MD, nouncement of Awards of Kinderklinik General Session (Hall D, der Universität Orange County ConvenTübingen in Tuebingen, tion Center). Germany, and Nancy A. Speck, PhD, of the UniverKarl Welte, MD sity of Pennsylvania PerelDr. Karl Welte's kindman School of Medicine ness and compassion are the recipients of the found an outlet through 2015 Henry M. Stratton his career in hematology. Medal for their outstandHe was drawn to the field ing careers in neutrophil as a young fellow in pedevelopment and treatNancy A. Speck, PhD Karl Welte, MD diatric hematology at the ment, and understanding of developmental hematopoiesis as Developmental Biology, Associ- University Hospital of the Free Uniwell as the translation of findings ate Director of Penn's Institute for versity of Berlin in 1976, where he into leukemogenesis, respectively. Regenerative Medicine, co-leader was treating children with hemaThis ASH Honorific Award, in- of the Hematologic Malignancies tologic disorders. "I met children spired by Henry Maurice Stratton, Program at Penn's Abramson Can- who suffered from leukemias and honors senior investigators whose cer Center, and Investigator at the wanted to help them, but in the time contributions to basic and clinical/ Abramson Family Cancer Research until 1970, the prognosis of survival translational hematologic research Institute. Drs. Speck and Welte will was very bad." He worked hard have had an impact on the field. Dr. each be presented with the Stratton and became the first to successfully Welte is Professor of Pediatrics, and Medal tomorrow, December 8, at »» STRATTON MEDAL Page B-14 Dr. Speck is Professor of Cell and  http://www.hematology.org/ashnewsdaily2015_monday

Table of Contents for the Digital Edition of ASH News Daily 2015 - Day 3

In This Section
In This Section

ASH News Daily 2015 - Day 3

https://www.nxtbookmedia.com